Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 106
Filter
Add more filters










Publication year range
1.
Neuroscience ; 172: 44-54, 2011 Jan 13.
Article in English | MEDLINE | ID: mdl-21034796

ABSTRACT

Feedback inhibition serves to modulate release when neurotransmitter levels in the synaptic cleft are elevated. The "classical" feedback auto-inhibition of neurotransmitter release is predominantly mediated by activation of presynaptic G-protein-coupled receptors (GPCRs) and exhibits slow kinetics. In cholinergic and glutamatergic synapses and for focal graded depolarization of the axon terminal, feedback inhibition was found to be voltage-dependent. At high depolarizations, such as the one produced by an action potential, low concentrations of neurotransmitter were insufficient to inhibit release. On the other hand, at higher neurotransmitter concentrations, feedback inhibition was observed also for action potential-evoked release. This finding suggests the presence of an additional mechanism of feedback inhibition that operates also at large presynaptic depolarizations. Using the glutamatergic crayfish neuromuscular junction we discovered a novel, extremely fast, form of feedback inhibition which hampers action potential-evoked release. This novel mechanism is pertussis toxin-insensitive, and is activated already 1 ms after flash photolysis producing glutamate concentrations higher than the ones required to activate the classical feedback inhibition. This finding implies that this mechanism is recruited only when glutamate levels in the synaptic cleft are relatively high (after high-frequency activation or in pathological conditions). We show that both the classical and this novel mechanism operate under physiological conditions.


Subject(s)
Astacoidea/physiology , Feedback, Physiological/physiology , Glutamic Acid/metabolism , Neural Inhibition/physiology , Neuromuscular Junction/physiology , Synaptic Transmission/physiology , Animals , Excitatory Postsynaptic Potentials/physiology , Glutamates/metabolism , Neuromuscular Junction/cytology , Photolysis , Synaptic Membranes/drug effects , Synaptic Membranes/physiology
2.
J Neurophysiol ; 96(3): 1053-60, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16760338

ABSTRACT

Peptides that inhibit the SNAP-stimulated ATPase activity of N-ethylmaleimide-sensitive fusion protein (NSF-2, NSF-3) were injected intra-axonally to study the role of this protein in the release of glutamate at the crayfish neuromuscular junction. Macropatch recording was used to establish the quantal content and to construct synaptic delay histograms. NSF-2 or NSF-3 injection reduced the quantal content, evoked by either direct depolarization of a single release bouton or by axonal action potentials, on average by 66 +/- 12% (mean +/- SD; n = 32), but had no effect on the time course of release. NSF-2 had no effect on the amplitude or shape of the presynaptic action potential nor on the excitatory nerve terminal current. Neither NSF-2 nor NSF-3 affected the shape or amplitude of single quantal currents. Injection of a peptide with the same composition as NSF-2, but with a scrambled amino acid sequence, failed to alter the quantal content. We conclude that, at the crayfish neuromuscular junction, NSF-dependent reactions regulate quantal content without contributing to the presynaptic mechanisms that control the time course of release.


Subject(s)
N-Ethylmaleimide-Sensitive Proteins/physiology , Neuromuscular Junction/physiology , Synaptic Transmission/physiology , Animals , Astacoidea , Brain/drug effects , Brain/physiology , Cricetinae , Electric Stimulation , Extremities/innervation , Microinjections , N-Ethylmaleimide-Sensitive Proteins/administration & dosage , N-Ethylmaleimide-Sensitive Proteins/genetics , N-Ethylmaleimide-Sensitive Proteins/pharmacology , Neuromuscular Junction/drug effects , Rats , Recombinant Proteins , Synapses/drug effects , Synapses/physiology , Walking
3.
J Neurophysiol ; 93(6): 3257-69, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15703226

ABSTRACT

The role of presynaptic muscarinic autoreceptors in the initiation of phasic acetylcholine (ACh) release at frog and mouse neuromuscular junctions was studied by measuring the dependency of the amount (m) of ACh release on the level of presynaptic depolarization. Addition of methoctramine (a blocker of M2 muscarinic receptors), or of acetylcholinesterase (AChE), increased release in a voltage-dependent manner; enhancement of release declined as the depolarizing pulse amplitude increased. In frogs and wild-type mice the slope of log m/log pulse amplitude (PA) was reduced from about 7 in the control to about 4 in the presence of methoctramine or AChE. In M2 muscarinic receptor knockout mice, the slope of log m/log PA was much smaller (about 4) and was not further reduced by addition of either methoctramine or AChE. The effect of a brief (0.1 ms), but strong (-1.2 microA) depolarizing prepulse on the dependency of m on PA was also studied. The depolarizing prepulse had effects similar to those of methoctramine and AChE. In particular, it enhanced release of test pulses in a voltage-dependent manner and reduced the slope of log m/log PA from about 7 to about 4. Methoctramine + AChE occluded the prepulse effects. In knockout mice, the depolarizing prepulse had no effects. The cumulative results suggest that initiation of phasic ACh release is achieved by depolarization-mediated relief of a tonic block imposed by presynaptic M2 muscarinic receptors.


Subject(s)
Acetylcholine/metabolism , Presynaptic Terminals/metabolism , Receptor, Muscarinic M2/physiology , Acetylcholinesterase/pharmacology , Animals , Diamines/pharmacology , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Electric Stimulation/methods , In Vitro Techniques , Linear Models , Mice , Mice, Knockout , Neuromuscular Junction/metabolism , Neuromuscular Junction/radiation effects , Parasympatholytics/pharmacology , Presynaptic Terminals/drug effects , Presynaptic Terminals/radiation effects , Rana ridibunda , Receptor, Muscarinic M2/deficiency , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , Synaptic Transmission/radiation effects , Time Factors
4.
J Comp Neurol ; 465(2): 250-62, 2003 Oct 13.
Article in English | MEDLINE | ID: mdl-12949785

ABSTRACT

The opener muscle of the dactyl of the walking leg of crayfish is innervated by one excitatory axon releasing glutamate and one inhibitory axon releasing GABA. Functional GABA(A) receptors are present postsynaptically on the muscle and presynaptically on terminals and release boutons of the excitatory axon, whereas presynaptic GABA(A) autoreceptors have not been reported on terminals or release boutons of the inhibitory axon. Using antibodies raised against mammalian GABA(A) receptor subunits alpha3 and beta(2/3), we obtained highly specific staining of the presynaptic membrane of the inhibitory bouton and of the postsynaptic membrane of the muscle. Using pre- and postembedding techniques, staining was localized to only presynaptic and postsynaptic membranes of synaptic active zones. We also found extrasynaptic receptor subunit immunoreactivity near (up to 100 nm) to the active zones. Staining with antibodies for the alpha3 and beta(2/3) subunits showed colocalization of particles of the two subunits. We suggest that presynaptic inhibitory boutons of the crayfish possess GABA(A)-like autoreceptors composed of at least the alpha3 and beta(2/3) subunits.


Subject(s)
Astacoidea/physiology , Muscle, Skeletal/innervation , Muscle, Skeletal/metabolism , Presynaptic Terminals/metabolism , Receptors, GABA-A/biosynthesis , Animals , Antibodies, Monoclonal , Cell Membrane/immunology , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Electric Stimulation , Freeze Substitution , Immunohistochemistry , Microscopy, Electron , Muscle, Skeletal/ultrastructure , Neural Inhibition/physiology , Neuromuscular Junction/metabolism , Neuromuscular Junction/ultrastructure , Presynaptic Terminals/ultrastructure , Protein Subunits/biosynthesis , Protein Subunits/immunology , Receptors, GABA-A/immunology
5.
J Neurophysiol ; 89(4): 1954-67, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12686574

ABSTRACT

We have previously suggested that presynaptic M(2)-muscarinic receptors (M(2)R) are involved in the control of the time course of evoked acetylcholine release in the frog neuromuscular junction. The availability of knockout mice lacking functional M(2)R (M(2)-KO) enabled us to address this issue in a more direct way. Using the phrenic diaphragm preparation, we show that in wild-type (WT) mice experimental manipulations known to affect Ca(2+) entry and removal, greatly affected the amount of acetylcholine released (quantal content). However, the time course of release remained unaltered under all these experimental treatments. On the other hand, in the M(2)-KO mice, similar experimental treatments affected both the quantal content and the time course of release. In general, a larger quantal content was accompanied by a longer duration of release. Similarly, the rise time of the postsynaptic current produced by axon stimulation was sensitive to changes in [Ca(2+)](o) or [Mg(2+)](o) in M(2)-KO mice but not in WT mice. Measurements of Ca(2+) currents revealed that the shorter rise time of the postsynaptic current seen in high [Mg(2+)](o) in M(2)-KO mice was not produced by a shorter wave of the presynaptic Ca(2+) current. These results support our earlier findings and provide direct evidence for the major role that presynaptic M(2)-muscarinic receptors play in the control of the time course of evoked acetylcholine release under physiological conditions.


Subject(s)
Acetylcholine/metabolism , Calcium/pharmacokinetics , Receptors, Muscarinic/genetics , Receptors, Muscarinic/metabolism , Synaptic Transmission/physiology , Action Potentials/physiology , Animals , Excitatory Postsynaptic Potentials/physiology , Extracellular Space/metabolism , Mice , Mice, Knockout , Presynaptic Terminals/metabolism , Receptor, Muscarinic M2 , Sodium/metabolism
6.
J Physiol ; 536(Pt 3): 717-25, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11691867

ABSTRACT

1. Macropatch recording was used to study release of acetylcholine in the frog neuromuscular junction evoked by either direct local depolarization or by an action potential. 2. The quantal content was established by directly counting the released quanta. The time course of release was obtained by constructing synaptic delay histograms. 3. Perfusion of the neuromuscular junction with methoctramine, a selective M(2)/M(4) muscarinic antagonist, increased the quantal content and slowed the exponential decay of the synaptic delay histograms. Addition of the agonist muscarine reversed these effects. 4. Addition of acetylcholinesterase prolonged the decay of the delay histogram, and muscarine reversed this effect. 5. Methoctramine slowed the rise time of the postsynaptic current produced by axon stimulation without affecting either the excitatory nerve terminal current or the presynaptic Ca(2+) current. 6. These results show that presynaptic M(2) muscarinic receptors are involved in the process which terminates evoked ACh release.


Subject(s)
Acetylcholine/physiology , Neuromuscular Junction/physiology , Receptors, Muscarinic/physiology , Receptors, Presynaptic/physiology , Acetylcholine/metabolism , Acetylcholinesterase/pharmacology , Algorithms , Animals , Calcium Channels/drug effects , Calcium Channels/metabolism , Diamines/pharmacology , Evoked Potentials/drug effects , In Vitro Techniques , Kinetics , Neuromuscular Junction/metabolism , Parasympatholytics , Rana ridibunda , Receptor, Muscarinic M2
7.
J Neurophysiol ; 84(3): 1240-6, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10979998

ABSTRACT

Presynaptic inhibition is produced by increasing Cl(-) conductance, resulting in an action potential of a smaller amplitude at the excitatory axon terminals. This, in turn, reduces Ca(2+) entry to produce a smaller release. For this mechanism to operate, the "inhibitory" effect of shunting should last during the arrival of the "excitatory" action potential to its terminals, and to achieve that, the inhibitory action potential should precede the excitatory action potential. Using the crayfish neuromuscular preparation which is innervated by one excitatory axon and one inhibitory axon, we found, at 12 degrees C, prominent presynaptic inhibition when the inhibitory action potential followed the excitatory action potential by 1, and even 2, ms. The presynaptic excitatory action potential and the excitatory nerve terminal current (ENTC) were not altered, and Ca(2+) imaging at single release boutons showed that this "late" presynaptic inhibition did not result from a reduction in Ca(2+) entry. Since 50 microM picrotoxin blocked this late component of presynaptic inhibition, we suggest that gamma-aminobutyric acid-A (GABA(A)) receptors reduce transmitter release also by a mechanism other than affecting Ca(2+) entry.


Subject(s)
Neural Inhibition/physiology , Neuromuscular Junction/physiology , Presynaptic Terminals/metabolism , Receptors, GABA-A/metabolism , Synaptic Transmission/physiology , Action Potentials/drug effects , Animals , Astacoidea , Baclofen/analogs & derivatives , Baclofen/pharmacology , Calcium/metabolism , Dose-Response Relationship, Drug , Electric Stimulation , Fura-2 , GABA Antagonists/pharmacology , GABA-A Receptor Antagonists , In Vitro Techniques , Intracellular Fluid/metabolism , Magnesium/metabolism , Magnesium/pharmacology , Neural Inhibition/drug effects , Neuromuscular Junction/drug effects , Patch-Clamp Techniques , Picrotoxin/pharmacology , Presynaptic Terminals/drug effects , Reaction Time/physiology , Synaptic Transmission/drug effects , Temperature , gamma-Aminobutyric Acid/metabolism , gamma-Aminobutyric Acid/pharmacology
8.
J Neurophysiol ; 84(1): 1-10, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10899178

ABSTRACT

Desensitization of crayfish glutamate channels was studied in outside-out patches employing an improved fast drug-application technique. Low concentrations of glutamate produced substantial desensitization without correlation with the detected number of open channels. The desensitization time constant (tau(D)) was found to be independent of glutamate concentration (0.3-20 mM). These results suggest that in addition to desensitization from a state of fully liganded channels, a substantial fraction of desensitization occurs also from channels in a partly-liganded state. A kinetic model was developed. The model accounts for the multifaceted behavior of desensitization as well as for resensitization.


Subject(s)
Ion Channel Gating/physiology , Models, Chemical , Receptors, AMPA/physiology , Animals , Astacoidea , Dose-Response Relationship, Drug , Glutamic Acid/pharmacology , Ion Channel Gating/drug effects , Kinetics , Ligands , Membrane Potentials/drug effects , Membrane Potentials/physiology , Muscles/chemistry , Patch-Clamp Techniques
9.
Trends Neurosci ; 23(2): 60-8, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10652546

ABSTRACT

It has been suggested that depolarization per se can control neurotransmitter release, in addition to its role in promoting Ca2+ influx. The 'Ca2+ hypothesis' has provided an essential framework for understanding how Ca2+ entry and accumulation in nerve terminals controls transmitter release. Yet, increases in intracellular Ca2+ levels alone cannot account for the initiation and termination of release; some additional mechanism is needed. Several experiments from various laboratories indicate that membrane potential has a decisive role in controlling this release. For example, depolarization causes release when Ca2+ entry is blocked and intracellular Ca2+ levels are held at an elevated level. The key molecules that link membrane potential with release control have not yet been identified: likely candidates are presynaptic autoreceptors and perhaps the Ca2+ channel itself.


Subject(s)
Exocytosis , Neurotransmitter Agents/metabolism , Receptors, Cell Surface/metabolism , Animals , Binding Sites , Calcium/metabolism , Calcium Channels/metabolism , Membrane Potentials , Models, Neurological
11.
J Neurophysiol ; 81(6): 3044-53, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10368419

ABSTRACT

The dependence of evoked and asynchronous release on intracellular calcium ([Ca2+]i) and presynaptic membrane potential was examined in single-release boutons of the crayfish opener neuromuscular junction. When a single bouton was depolarized by a train of pulses, [Ca2+]i increased to different levels according to the frequency of stimulation. Concomitant measurements of evoked release and asynchronous release, from the same bouton, showed that both increased in a sigmoidal manner as a function of [Ca2+]i. When each of the depolarizing pulses was immediately followed by a hyperpolarizing pulse, [Ca2+]i was elevated to a lesser degree than in the control experiments, and the rate of asynchronous release and the quantal content were reduced; most importantly, evoked quantal release terminated sooner. The diminution of neurotransmitter release by the hyperpolarizing postpulse (HPP) could not be entirely accounted for by the reduction in [Ca2+]i. The experimental results are consistent with the hypothesis that the HPP reduces the sensitivity of the release machinery to [Ca2+]i, thereby not only reducing the quantal content but also terminating the quantal release process sooner.


Subject(s)
Calcium/metabolism , Neuromuscular Junction/metabolism , Neurotransmitter Agents/metabolism , Animals , Astacoidea , Calcium Channels/physiology , Cell Membrane/physiology , Fluorescent Dyes , Fura-2 , In Vitro Techniques , Magnesium/physiology , Membrane Potentials/physiology
12.
J Neurophysiol ; 81(3): 1184-91, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10085345

ABSTRACT

Release of excitatory transmitter from boutons on crayfish nerve terminals was inhibited by (R,S)-baclofen, an agonist at GABAB receptors. Baclofen had no postsynaptic actions as it reduced quantal content without affecting quantal amplitude. The effect of baclofen increased with concentration producing 18% inhibition at 10 microM; EC50, 50% inhibition at 30 microM; maximal inhibition, 85% at 100 microM and higher. There was no desensitization, even with 200 or 320 microM baclofen. Phaclofen, an antagonist at GABAB receptors, competitively antagonized the inhibitory action of baclofen (KD = 50 microM, equivalent to a pA2 = 4.3 +/- 0.1). Phaclofen on its own at concentrations below 200 microM had no effect on release, whereas at 200 microM phaclofen itself increased the control level of release by 60%, as did 2-hydroxy-saclofen (200 microM), another antagonist at GABAB receptors. This increase was evidently due to antagonism of a persistent level of GABA in the synaptic cleft, since the effect was abolished by destruction of the presynaptic inhibitory fiber, using intra-axonal pronase. We conclude that presynaptic GABAB receptors, with a pharmacological profile similar to that of mammalian GABAB receptors, are involved in the control of transmitter release at the crayfish neuromuscular junction.


Subject(s)
Neuromuscular Junction/physiology , Receptors, GABA-B/physiology , Receptors, Presynaptic/physiology , Animals , Astacoidea , Axons/drug effects , Baclofen/analogs & derivatives , Baclofen/pharmacology , GABA Agonists/pharmacology , GABA Antagonists/pharmacology , Logistic Models , Neural Inhibition/drug effects , Neuromuscular Junction/drug effects , Patch-Clamp Techniques , Pronase , Quantum Theory , Receptors, GABA-B/drug effects , Receptors, Presynaptic/drug effects
13.
J Neurophysiol ; 81(2): 634-42, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10036266

ABSTRACT

The opener neuromuscular junction of crayfish was used to determine the affinity of the putative Ca2+ receptor(s) responsible for evoked release. Evoked, asynchronous release, and steady-state intracellular Ca2+ concentration, [Ca2+]ss, were measured concomitantly in single release boutons. It was found that, as expected, asynchronous release is highly correlated with [Ca2+]ss. Surprisingly, evoked release was also found to be highly correlated with [Ca2+]ss. The quantal content (m) and the rate of asynchronous release (S) showed sigmoidal dependence on [Ca2+]ss. The slope log m/log [Ca2+]ss varied between 1.6 and 3.3; the higher slope observed at the lower [Ca2+]o. The slope log S/log [Ca2+]ss varied between 3 and 4 and was independent of [Ca2+]o. These results are consistent with the assumption that evoked release is controlled by the sum of [Ca2+]ss and the local elevation of Ca2+ concentration near the release sites resulting from Ca2+ influx through voltage-gated Ca2+ channels (Y). On the basis of the above, we were able to estimate Y. We found Y to be significantly <10 microM even for [Ca2+]o = 13.5 mM. The dissociation constant (Kd) of the Ca2+ receptor(s) associated with evoked release was calculated to be in the range of 4-5 microM. This value of Kd is similar to that found previously for asynchronous release.


Subject(s)
Calcium/metabolism , Intracellular Fluid/metabolism , Presynaptic Terminals/metabolism , Animals , Astacoidea , Calcium Channels/metabolism , Electric Stimulation , Extracellular Space/metabolism , Fluorescent Dyes , Fura-2 , Models, Neurological , Models, Theoretical , Neuromuscular Junction/metabolism , Neurotransmitter Agents/metabolism
14.
J Physiol ; 514 ( Pt 3): 769-82, 1999 Feb 01.
Article in English | MEDLINE | ID: mdl-9882749

ABSTRACT

1. Presynaptic effects of muscarine on neurotransmitter release were studied at the frog neuromuscular junction, using focal depolarization of the presynaptic terminal to different levels. 2. Muscarine (10 microM) had a dual effect on ACh release: concomitant inhibition and enhancement of release at the same patch of presynaptic membrane. 3. These two effects were maximal at low depolarizing pulses and diminished as depolarization increased. 4. At low depolarizing pulses, atropine (1 microM) enhanced release, suggesting that ACh in the synaptic cleft causes a net tonic inhibition of ACh release. 5. In the presence of the M2 antagonist methoctramine (1 microM), muscarine (10 microM) enhanced ACh release. 6. In the presence of the M1 antagonist pirenzepine (10 microM), muscarine (10 microM) produced stronger inhibition. 7. These results show that the M2 receptor is responsible for inhibition of ACh release, while the M1 receptor is responsible for its enhancement. 8. The inhibitory effect of muscarine did not depend on extracellular [Ca2+]. Enhancement of release was abolished at low extracellular [Ca2+]. 9. The muscarine inhibitory effect was not associated with a reduction of Ca2+ current, while release enhancement was associated with an increase of Ca2+ current.


Subject(s)
Acetylcholine/metabolism , Muscarine/pharmacology , Muscarinic Agonists/pharmacology , Neuromuscular Junction/metabolism , Receptors, Presynaptic/drug effects , Animals , Atropine/pharmacology , Calcium Channels/drug effects , Calcium Channels/metabolism , In Vitro Techniques , Membrane Potentials/physiology , Muscarinic Antagonists/pharmacology , Neuromuscular Junction/drug effects , Patch-Clamp Techniques , Rana ridibunda
15.
J Neurophysiol ; 80(6): 2893-9, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9862893

ABSTRACT

Functional and immunocytochemical identification of glutamate autoreceptors of an NMDA type in crayfish neuromuscular junction. J. Neurophysiol. 80: 2893-2899, 1998. N-Methyl--aspartate (NMDA) reduces release from crayfish excitatory nerve terminals. We show here that polyclonal and monoclonal antibodies raised against the mammalian postsynaptic NMDA receptor subunit 1 stain specifically the presynaptic membrane of release boutons of the crayfish neuromuscular junction. In crayfish ganglionic membranes, the polyclonal antibody recognizes a single protein band that is somewhat larger (by approximately 30 kD) than the molecular weight of the rat receptor. Moreover, the monoclonal (but not the polyclonal) antibody abolishes the physiological effect of NMDA on glutamate release. The monoclonal antibody did not prevent the presynaptic effects of glutamate, which also reduces release by activation of quisqualate presynaptic receptors. Only when 6-cyano-7-nitroquinoxatine-2,3,dione (CNQX) was added together with the monoclonal antibody was the presynaptic effect of glutamate blocked. These results show that presynaptic glutamate receptors of the crayfish NMDA type are involved in the regulation of neurotransmitter release in crayfish axon terminals. Although the crayfish receptor differs in its properties from the mammalian NMDA receptor, the two receptors retained some structural similarity.


Subject(s)
Astacoidea/physiology , Autoreceptors/metabolism , Neuromuscular Junction/physiology , Receptors, N-Methyl-D-Aspartate/metabolism , Animals , Antibodies, Blocking/pharmacology , Autoreceptors/drug effects , Autoreceptors/ultrastructure , Blotting, Western , Electrophysiology , Excitatory Amino Acid Agonists/pharmacology , Immunohistochemistry , In Vitro Techniques , Microscopy, Electron , Muscles/cytology , Muscles/drug effects , Muscles/metabolism , N-Methylaspartate/pharmacology , Neuromuscular Junction/drug effects , Neuromuscular Junction/ultrastructure , Presynaptic Terminals/drug effects , Presynaptic Terminals/physiology , Rats , Receptors, N-Methyl-D-Aspartate/drug effects , Receptors, N-Methyl-D-Aspartate/ultrastructure
16.
J Exp Biol ; 201(Pt 6): 779-91, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9464959

ABSTRACT

Peripheral axons of lobsters can survive for many months after axotomy. We have investigated the structural and ultrastructural changes seen after axotomy using confocal microscopy and electron microscopy. While the proximal stump had a normal appearance, the distal part of the cut axon became lobulated, and glial cells penetrated the original glial tube (axon tube) in which the axon normally runs. The changes proceeded from the cut end towards the muscle. As time elapsed, the axon tube seemed to be filled with glial cells, but interposed small profiles of the original axon could be identified by injection of a fluorescent dye into the axon. The glial cells send cytoplasmic projections deep into folds of the axolemma, and nuclei were found at the end of these long processes. Proliferation of glial cells was also seen.


Subject(s)
Axons/physiology , Nephropidae/anatomy & histology , Nephropidae/physiology , Abdomen/innervation , Animals , Axotomy , Microscopy, Confocal , Microscopy, Electron , Neuroglia/physiology , Neuroglia/ultrastructure
17.
Biophys J ; 74(4): 1767-78, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9545039

ABSTRACT

We have studied the voltage sensitivity of glutamate receptors in outside-out patches taken from crayfish muscles. We found that single-channel conductance, measured directly at the single-channel level, increases as depolarization rises. At holding potentials from -90 mV to approximately 20 mV, the conductance is 109 pS. At holding potentials positive to 20 mV, the conductance is 213 pS. This increase in single-channel conductance was also observed in cell-attached patches. In addition, desensitization, rise time, and the dose-response curve were all affected by depolarization. To further clarify these multifaceted effects, we evaluated the kinetic properties of single-channel activity recorded from cell-attached patches in hyperpolarization (membrane potential around -75 mV) and depolarization (membrane potential approximately 105 mV). We found that the glutamate dissociation rate constant (k_) was affected most significantly by membrane potential; it declined 6.5-fold under depolarization. The rate constant of channel closing (k(c)) was also significantly affected; it declined 1.8-fold. The rate constant of channel opening (k(o)) declined only 1.2-fold. The possible physiological significance of the depolarization-mediated changes in the above rate constants is discussed.


Subject(s)
Astacoidea/metabolism , Ion Channels/metabolism , Receptors, Glutamate/metabolism , Animals , Biophysical Phenomena , Biophysics , Dose-Response Relationship, Drug , Electric Conductivity , Glutamic Acid/administration & dosage , Ion Channels/drug effects , Kinetics , Membrane Potentials/drug effects , Muscles/drug effects , Muscles/metabolism , Patch-Clamp Techniques , Receptors, Glutamate/drug effects
18.
J Physiol ; 501 ( Pt 2): 251-62, 1997 Jun 01.
Article in English | MEDLINE | ID: mdl-9192298

ABSTRACT

1. A technique has been developed to monitor neurotransmitter release simultaneously with intracellular Ca2+ concentration ([Ca2+]i) in single release boutons whose diameters range from 3 to 5 microns. 2. Using this technique, we have found a highly non-linear relationship between the rate of asynchronous release and [Ca2+]i. The Hill coefficient lies between 3 and 4. 3. The affinity (Kd) of the putative release-related Ca2+ receptor for asynchronous release was calculated to be in the range of 2-4 microM. 4. The same range of values of Hill coefficient and Kd were obtained when [Ca2+]i was elevated both by bath application of ionomycin and by repetitive stimulation at high frequency. 5. Our results show that the Ca2+ receptor(s) associated with asynchronous release exhibits high affinity for Ca2+.


Subject(s)
Astacoidea/physiology , Calcium/metabolism , Muscles/innervation , Neurons/metabolism , Neurotransmitter Agents/metabolism , Animals , Calibration , Electric Stimulation , Fluorescent Dyes , Fura-2/analogs & derivatives , Image Processing, Computer-Assisted , In Vitro Techniques , Kinetics , Muscles/physiology , Synapses/metabolism , Synapses/physiology
19.
J Neurophysiol ; 76(6): 3807-16, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8985878

ABSTRACT

1. Presynaptic inhibition of excitatory transmitter release evoked by inhibitory axon stimulation was studied at individual release boutons of the crayfish opener neuromuscular junction. 2. Presynaptic inhibition was maximal (approximately 30%) when a single inhibitory action potential preceded the excitatory test action potential by 1-2 ms. This inhibition lasted at most 5 ms. It was blocked by 50 microM picrotoxin, and is probably mediated mainly by gamma-aminobutyric acid-A (GABAA) receptors. 3. Presynaptic inhibition produced by a brief train of inhibitory action potentials (5 pulses at 100 Hz) was maximal (approximately 60%) when the last inhibitory action potential (of the train) preceded the excitatory test action potential by 10 ms. This inhibition lasted up to 50 ms. It seems that in this case GABAB receptors were activated as well, because the combined action of picrotoxin (50 microM) and 20H-Saclofen (100 microM) was required to block the inhibition. 4. We thus show that one and the same inhibitory release bouton can differentially activate two distinct mechanisms for presynaptic inhibition by activating GABAA and GABAB receptors.


Subject(s)
Axons/physiology , Neural Inhibition/physiology , Neuromuscular Junction/physiology , Neurotransmitter Agents/metabolism , Presynaptic Terminals/physiology , Action Potentials/drug effects , Action Potentials/physiology , Animals , Astacoidea , Axons/drug effects , Baclofen/analogs & derivatives , Baclofen/pharmacology , Electric Stimulation , GABA Antagonists , Neural Inhibition/drug effects , Neuromuscular Junction/drug effects , Neuromuscular Junction/metabolism , Picrotoxin/pharmacology , Presynaptic Terminals/drug effects , Receptors, GABA-A/physiology , Receptors, GABA-B/physiology
20.
J Neurophysiol ; 75(4): 1377-85, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8727384

ABSTRACT

1. Presynaptic inhibition in crustaceans involves the activation of gamma-aminobutyric acid-A (GABAA) receptors that produce an increase in chloride conductance at excitatory axon terminals. Such inhibition produced by single inhibitory pulses is blocked by picrotoxin, a GABAA antagonist. 2. Presynaptic inhibition produced by bath application of GABA was not blocked by picrotoxin. Measurements of the membrane resistance of the excitatory axon terminals revealed that substantial presynaptic inhibition still persisted after 50 microM picrotoxin had completely blocked the increase in conductance produced by 10 microM GABA. 3. Baclofen, a GABAB agonist, reduced release from the excitatory nerve terminals, and 20H-Saclofen, a GABAB antagonist, blocked the effect of baclofen and the presynaptic inhibition produced by 10 microM GABA. 4. 20H-Saclofen alone did not block presynaptic inhibition produced by 100 microM GABA, and the combined action of both 20H-Saclofen and picrotoxin was required to block such effects. 5. The excitatory nerve terminals seem to contain GABAA and GABAB receptors. The GABAB receptors are preferentially activated at lower GABA concentrations (in the microM range), whereas both the GABAA and GABAB receptors are activated at high GABA concentrations.


Subject(s)
GABA-A Receptor Agonists , Neural Inhibition/drug effects , Neuromuscular Junction/drug effects , Presynaptic Terminals/drug effects , gamma-Aminobutyric Acid/pharmacology , Animals , Astacoidea , Baclofen/analogs & derivatives , Baclofen/pharmacology , GABA Agonists/pharmacology , GABA Antagonists/pharmacology , GABA-A Receptor Antagonists , Membrane Potentials/drug effects , Neural Conduction/drug effects , Neuromuscular Junction/physiology , Picrotoxin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...